The specificity of MOG in ODCs suggests that the MOG gene may present with unique methylation patterns in ODCs, which can be used to detect ODC-derived DNA in the blood and assess disease activity in patients with MS. The gene discussed is MOG; the disease is myeloid sarcoma.